|
|
|
|
|
Products
Ninotalem' - High quality melatonin tablets
Melatonin is a natural hormone that is produced by the pineal gland,
located in the human brain. It plays a vital role in the regulation of
the body' circadian rhythm, also known as the 'biological clock'.
Ninotalem' tablets contain a chemically synthesized melatonin that meets
all regulatory quality requirements for the use in human medicinal
products. Melatonin is used worldwide for disorders related to
disturbances in the circadian rhythm, such as jet-lag and sleep
disorders.
What makes Ninotalem' stand out from other brands of melatonin products
is its high quality and consistency. Furthermore, in contrast to the
majority of existing brands, Ninotalem' can boast a proven track record
in a range of clinical trials.
In 2006, Circa Dia obtained a product license for Ninotalem' from Health
Canada. The quality dossier meets all requirements for a
melatonin-containing product to be commercialized in Canada. Ninotalem'
is indicated for sleep disorders and jet-lag and will become available
without prescription. Health Canada considers melatonin to be a natural
health product that requires a product license.
Ninotalem' 5 mg tablets - Product Information
Ninotalem' is available as white to off-white circular tablets
(diameter: 5 mm, average weight: 75 mg). Each tablet contains 5 mg
synthetic melatonin.
Ninotalem' contains the following non-medicinal ingredients: calcium
hydrogen phosphate, dihydrate, mannitol, sodium starch glycolate, talc
and magnesium stearate.
Packaging: Ninotalem' tablets are packed in aluminum/pentalayer blisters
with 10 tablets per blister. The blisters are packed, together with an
information leaflet on the product and its usage, in a carton box.
Stability and storage: Ninotalem' tablets packed in aluminum/pentalayer
blisters are stable for at least five years. Storage at room temperature
in a dry, dark environment is advised.
Ninotalem' - Quality
Ninotalem' tablets contain a chemically synthesized melatonin that meets all regulatory requirements.
Active Pharmaceutical Ingredient (API): Melatonin
Manufacturing, packaging, quality control and quality assurance release
of API melatonin are performed in full compliance with current Good
Manufacturing Practices (GMP).
The stability testing program (long term and accelerated stability) is
performed in compliance with ICH guidelines. Stability data of 60 months
are currently available.
Ninotalem' tablets
Production, packaging, quality control and quality assurance release of
Ninotalem' tablets are performed in full compliance with current GMP and
PIC-regulations as recommended by the World Health Organization (WHO).
The excipients are commonly used for direct compression tablets and are manufactured according to EP/USP quality standards.
The release specifications (test parameters, test methods and acceptance
limits) of Ninotalem' tablets are in line with the European
Pharmacopoeia.
The stability testing program (long term and accelerated stability) is
performed in compliance with ICH guidelines. Stability data of 60 months
are available. Ninotalem' tablets are stable for at least five years.
|
|
|
|
|
Circa Dia B.V. - Herengracht 124 - 1015 BT Amsterdam - The Netherlands T +31 (0)20 5205820 F +31 (0)20 5205810 E Elke.van.Wachem@circadia.nl |
|
|
|